CALL FOR PAPERS

Author Information

CERTIFICATE

IMPACT FACTOR 2021

Subject Area

Life Sciences / Biology
Architecture / Building Management
Asian Studies
Business & Management
Chemistry
Computer Science
Economics & Finance
Engineering / Acoustics
Environmental Science
Agricultural Sciences
Pharmaceutical Sciences
General Sciences
Materials Science
Mathematics
Medicine
Nanotechnology & Nanoscience
Nonlinear Science
Chaos & Dynamical Systems
Physics
Social Sciences & Humanities

Why Us? >>

Open Access
Peer Reviewed
Rapid Publication
Life time hosting
Free promotion service
Free indexing service
More citations
Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Sars cov-2 breakthrough infections – is it an area of concern?

Author:

Sonia Puri, Varsha Gupta, Praizy Bhandari, Ravneet Kaur, Shreyas Mishra and Tulika Garg

Subject Area:

Health Sciences

Abstract:

The devastating morbidity and mortality caused by SARS COV-2 pandemic led to spurred research for development of vaccines against the SARS-CoV2 virus. Usually, the development of a new vaccine takes 10–15 years, but the search for a vaccine against SARS-CoV2 moved at a breakneck speed, with numerous research institutions and vaccine producers nearing a breakthrough in vaccine development within 15-18 months. At present numerous vaccines are available but vaccines do not confer 100% immunity. Emerging new variants are a constant worry about breakthrough infections globally. However, there isn't enough data to state whether insufficient vaccine-induced immunogenicity caused breakthrough infections during the variant's outbreak. There are concerns regarding the occurrence of breakthrough infections after vaccination, and it is still a topic of exploration.

PDF file: